Ozempic Maker Novo Nordisk’s Investors Are Nervously Looking Into the Future
Sep 01, 2026
Novo Nordisk’s chief executive, Mike Doustdar, is a year into a corporate turnaround. He says investors are still underestimating the promise of the company’s drugs.
https://www.nytimes.com/2026/09/01/business/novo-nordisk-ozempic-wegovy-glp1s-stocks.html
Respond, make new discussions, see other discussions and customize your news...

To add this website to your home screen:

1. Tap tutorialsPoint

2. Select 'Add to Home screen' or 'Install app'.

3. Follow the on-scrren instructions.

Feedback
FAQ
Privacy Policy
Terms of Service